Drug Information

Drug General Information
Drug ID
D0N6TD
Former ID
DNCL002532
Drug Name
BIW-8962
Drug Type
Antibody
Indication Multiple myeloma [ICD9: 203; ICD10:C90] Phase 1/2 [524360]
Company
Kyowa Hakko Kirin Pharma
Target and Pathway
Target(s) Ganglioside GM2 activator Target Info [531613], [550437]
NetPath Pathway TGF_beta_Receptor Signaling Pathway
References
Ref 524360ClinicalTrials.gov (NCT01898156) Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer. U.S. National Institutes of Health.
Ref 531613Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells. Cancer Sci. 2011 Dec;102(12):2157-63.
Ref 550437National Cancer Institute Drug Dictionary (drug id 618862).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.